Breakthrough for Breast Cancer Treatment at Salamanca University

Today, news was published about some groundbreaking progress made by the Cancer Research Centre of the University of Salamanca.

A group of scientists, led by Atanasio Pandiella, has developed a new treatment for breast cancer, which works by combining two different drugs, Dasatinib and Hercepin. So far, research has shown that this medication manages to both eliminate tumours and prevent their re-growth, even once the course of drugs has finished.

This exciting discovery is the result of three years of work by scientists at the Cancer Research Centre. So far, the method has only been tested on mice carrying tumour cells very similar to those of breast-cancer sufferers. In just over a month, however, the drugs will be clinically trialled on 40 women in Spanish hospitals, and results of these tests will be available in around a year's time.

As the most prevalent type of cancer in the world, breast cancer currently claims the lives of 410,000 women each year, accounting for 1.6% of female deaths globally. With such pioneering research taking place, there is certainly reason to feel encouraged that these statistics might soon be reduced.